Sir Peter Karel, Baron Piot, is a Belgian-British microbiologist known for his research into Ebola and AIDS.
Health policy can be defined as the "decisions, plans, and actions that are undertaken to achieve specific healthcare goals within a society". According to the World Health Organization, an explicit health policy can achieve several things: it defines a vision for the future; it outlines priorities and the expected roles of different groups; and it builds consensus and informs people.
Health technology assessment (HTA) is a multidisciplinary process that uses systematic and explicit methods to evaluate the properties and effects of a health technology. Health technology is conceived as any intervention at any point in its lifecycle. HTA aim is to inform "decision-making in order to promote an equitable, efficient, and high-quality health system". It has other definitions including "a method of evidence synthesis that considers evidence regarding clinical effectiveness, safety, cost-effectiveness and, when broadly applied, includes social, ethical, and legal aspects of the use of health technologies. The precise balance of these inputs depends on the purpose of each individual HTA. A major use of HTAs is in informing reimbursement and coverage decisions by insurers and national health systems, in which case HTAs should include benefit-harm assessment and economic evaluation." And "a multidisciplinary process that summarises information about the medical, social, economic and ethical issues related to the use of a health technology in a systematic, transparent, unbiased, robust manner. Its aim is to inform the formulation of safe, effective, health policies that are patient focused and seek to achieve best value. Despite its policy goals, HTA must always be firmly rooted in research and the scientific method".
The National Institute for Health and Care Research (NIHR) is the British government’s major funder of clinical, public health, social care and translational research. With a budget of over £1.2 billion in 2020–21, its mission is to "improve the health and wealth of the nation through research". The NIHR was established in 2006 under the government's Best Research for Best Health strategy, and is funded by the Department of Health and Social Care. As a research funder and research partner of the NHS, public health and social care, the NIHR complements the work of the Medical Research Council. NIHR focuses on translational research, clinical research and applied health and social care research.
David M. Eddy is an American physician, mathematician, and healthcare analyst who has done seminal work in mathematical modeling of diseases, clinical practice guidelines, and evidence-based medicine. Four highlights of his career have been summarized by the Institute of Medicine of the National Academy of Sciences: "more than 25 years ago, Eddy wrote the seminal paper on the role of guidelines in medical decision-making, the first Markov model applied to clinical problems, and the original criteria for coverage decisions; he was the first to use and publish the term 'evidence-based'."
Sir Michael David Rawlins was a British clinical pharmacologist and emeritus professor at the University of Newcastle upon Tyne. During his medical career he chaired several executive agencies including the Committee on Safety of Medicines from 1993 to 1998, followed by the National Institute for Health and Care Excellence (NICE) for 14 years from its formation in 1999 and then the Medicines and Healthcare products Regulatory Agency (MHRA) for six years from 2014. From 2012 to 2014 he was president of the Royal Society of Medicine.
Anthony John (Tony) Culyer CBE is a British economist, and emeritus professor of economics at the University of York, visiting professor at Imperial College London and adjunct professor in health policy, evaluation and management at the University of Toronto, known for his work in the field of health economics.
Gillian Catherine Leng, Lady Cosford CBE is a British health administrator, academic, visiting professor at King's College London and the former Chief Executive of the National Institute for Health and Care Excellence (NICE), where she was responsible for several programmes and guidelines including the guidelines on COVID-19. In 2023 she was elected president-elect of the Royal Society of Medicine (RSM).
Cerner Enviza is an American healthcare company that provides data, analytics, and research to the life sciences industry, with a particular focus on oncology and rare diseases.
ISPOR—The Professional Society for Health Economics and Outcomes Research, better known as ISPOR, is a nonprofit global professional organization in health economics and outcomes research. It was founded in 1995 as an international multidisciplinary professional organization that advances the policy, science, and practice of pharmacoeconomics and outcomes research. The society's mission is to promote health economics and outcomes research to improve decision making for health globally.
John Norman Lavis is a Canadian physician based in Toronto, Ontario. He is a tenured professor in the Department of Health Evidence and Impact at McMaster University, where he founded and directs the McMaster Health Forum. He is co-lead of Rapid-Improvement Support and Exchange (RISE).
Jocalyn Clark is a Canadian Public Health Scientist and the International Editor of The BMJ, with responsibility for strategy and internationalising the journal's content, contributors and coverage. From 2016 to 2022, Jocalyn was an Executive Editor at The Lancet, where she led the Commentary section, coordinated peer review, and edited and delivered collections of articles and Commissions on topics such as maternal and child health, oral health, migration, end of life care and gender equity. She led the Lancet's project to advance women in science, medicine, and global health, #LancetWomen. She is also an Adjunct Professor of Medicine at the University of Toronto and an Honorary Associate Professor at the Institute for Global Health at UCL.
Catherine Kyobutungi is an Ugandan epidemiologist who currently serves as the Executive Director of the African Population and Health Research Center and a Joep Lange Chair. She was elected to the African Academy of Sciences in 2018.
Jennifer Dixon, CBE, MBChB, FRCP, FFPH, is the chief executive of the Health Foundation, a large independent charity in the United Kingdom. Her work has been recognised by several national and international bodies for her significant impact in driving national health policy making.
Neil Morris Ferguson is a British epidemiologist and professor of mathematical biology, who specialises in the patterns of spread of infectious disease in humans and animals. He is the director of the Jameel Institute, and of the MRC Centre for Global Infectious Disease Analysis, and head of the Department of Infectious Disease Epidemiology in the School of Public Health and Vice-Dean for Academic Development in the Faculty of Medicine, all at Imperial College London.
Rachelle Buchbinder is an Australian rheumatologist and clinical epidemiologist. Her clinical practice is in conjunction with research involving multidisciplinary projects relating to arthritis and musculoskeletal conditions. She promotes improvement of communication with patients and health literacy in the community.
Mousumi Banerjee is an Indian-American statistician and singer. She is the Anant M. Kshirsagar Collegiate Research Professor of Biostatistics and Director of the Center for Healthcare Outcomes and Policy (CHOP) at the University of Michigan. Banerjee is also the executive director of the nonprofit art foundation Tagore Beyond Boundaries.
The Abdul Latif Jameel Institute for Disease and Emergency Analytics is a research institute at Imperial College London in the fields of epidemiology, mathematical modelling of infectious diseases and emergencies, environmental health, and health economics. Co-founded in 2019 by Imperial College London and Community Jameel, the Jameel Institute is housed in the School of Public Health, within the college's Faculty of Medicine. The mission of the Jameel Institute is "to combat threats from disease worldwide".
The Institute of Global Health Innovation is one of Imperial College London’s global challenge Institutes. Established in 2010, its mission is to improve global health and care through evidence-based innovation. The Institute’s work aims to support the identification, development and implementation of healthcare innovation, with the goal of sustainably reducing inequalities in global health.
Kirsten McCaffery is a British-Australian public health researcher who is Principal Research Fellow and Director of Research at the Sydney School of Public Health. Her research considers the psychosocial aspects of over diagnosis in healthcare. She was elected Fellow of the Australian Academy of Health and Medical Sciences in 2020.
